Clinical Application of Bacteriophage Therapy in Children

Nanda Ramchandar1,2,3,4, John S Bradley2,4

  • 1Naval Medical Center San Diego, San Diego, California.

Pediatrics
|February 10, 2025
PubMed

Insights

Bacteriophages offer a precise alternative to antibiotics for treating bacterial infections in children, preserving their microbiome. This review explores their potential in pediatric precision antimicrobial therapy.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Antimicrobial Therapy

Background:

  • Bacteriophages are viruses that infect bacteria, offering high specificity for targeted pathogen elimination.
  • Current research on bacteriophage therapy is extensive in adults, but data in pediatric populations remain limited.
  • Antibiotic therapies can disrupt the beneficial pediatric microbiome, necessitating alternative treatments.

Purpose of the Study:

  • To review bacteriophages as a novel antimicrobial approach for pediatric infections.
  • To discuss the potential of bacteriophage therapy in precision medicine for children.
  • To highlight research gaps and future directions for bacteriophage applications in pediatrics.

Main Methods:

  • Literature review of bacteriophage therapy in adult and pediatric contexts.
  • Discussion of bacteriophage specificity and microbiome-sparing effects.
  • Exploration of practical considerations, limitations, and administration routes (topical and systemic).

Main Results:

  • Bacteriophages demonstrate high specificity against target pathogens, minimizing collateral damage to the microbiome.
  • Pediatric application presents an opportunity for precision antimicrobial strategies, especially for multidrug-resistant infections.
  • Potential exists for bacteriophages as primary or adjunctive therapy in children.

Conclusions:

  • Bacteriophage therapy holds significant promise for pediatric infectious diseases, offering a microbiome-sparing alternative.
  • Further pediatric research is crucial to establish safety, efficacy, and optimal application protocols.
  • This approach could revolutionize directed, precision antimicrobial treatments for infants and children.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.2K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.7K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
374
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K